Cytoreductive HIPEC-Combined Surgery in Treatment of Advanced Ovarian Cancer

Background . Ovarian cancer ranks 5th in the structure of female oncological mortality Russian Federation, with a first-year post-diagnosis rate almost 35%. In 75% cases, ovarian is diagnosed at stages III—IV. The disease usually represents as peritoneal carcinomatosis regarded an advanced form that demands attention, which renders issue highly relevant. We present literature review and analysis combined treatment outcomes patients hospitalised Kuvatov Republican Clinical Hospital within period 2020—2021. Materials methods article reviews foreign national scientific literature, well reports case data on 18 treated Department Oncology Results discussion A complete cytoreductive surgery was performed 100% cases. cohort I, mean operation time 256 vs. 364 min, intraoperative blood loss — 1200 1050 mL, hospital stay 14.6 18.7 bed-days. Postoperative complications were 16.7 50% I II. 30-day 0 16.6% monitoring enrolment currently continues. Conclusion HIPEC procedure not radical measure can only achieve maximum efficacy if coupled cytoreduction. stage III—IV concurrent approach promising requires further in-depth research more robust statistics.